The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.
Beteiligte Einrichtungen
Abstract
Only a minority of patients with malignant gliomas respond to continuous high-dose tamoxifen (TAM) treatment. Therefore a method to predict the efficiency of TAM-treatment would be desirable. Analogous to previous studies in breast cancer patients, we investigated whether the dynamics of TGF-beta2 plasma levels allow the prediction of response to TAM-treatment in glioblastoma patients as well.
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 1 |
| ISSN | 0250-7005 |
| Status | Veröffentlicht - 2002 |
| pubmed | 12017331 |
|---|
